A real-world study followed individuals who started GLP-1 medications and discontinued them within 3 to 12 months to assess weight changes after stopping treatment. One year after discontinuation, average weight regain was small. People in the obesity group regained about 0.5%, while those in the diabetes group lost an additional 1.3% on average, though individual outcomes varied.

Source: Medical News Today